B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax Merozoite Surface Protein-3α (PvMSP-3 α) in malaria exposed individuals from Brazilian Amazon

Laboratory of Immunoparasitology, Institute Oswaldo Cruz, Fiocruz, Rio de Janeiro, RJ, Brazil.
Vaccine (Impact Factor: 3.62). 02/2011; 29(9):1801-11. DOI: 10.1016/j.vaccine.2010.12.099
Source: PubMed


The Plasmodium vivax Merozoite Surface Protein-3α (PvMSP-3α) is considered as a potential vaccine candidate. However, the detailed investigations of the type of immune responses induced in naturally exposed populations are necessary. Therefore, we aim to characterize the naturally induced antibody to PvMSP-3α in 282 individuals with different levels of exposure to malaria infections residents in Brazilian Amazon. PvMSP3 specific antibodies (IgA, IgG and IgG subclass) to five recombinant proteins and the epitope mapping by Spot-synthesis technique to full-protein sequence of amino acids (15aa sequence with overlapping sequence of 9aa) were performed. Our results indicates that PvMSP3 is highly immunogenic in naturally exposed populations, where 78% of studied individuals present IgG immune response against the full-length recombinant protein (PVMSP3-FL) and IgG subclass profile was similar to all five recombinant proteins studied with a high predominance of IgG1 and IgG3. We also observe that IgG and subclass levels against PvMSP3 are associated with malaria exposure. The PvMSP3 epitope mapping by Spot-synthesis shows a natural recognition of at least 15 antigenic determinants, located mainly in the two blocks of repeats, confirming the high immunogenicity of this region. In conclusion, PvMSP-3α is immunogenic in naturally exposed individuals to malaria infections and that antibodies to PvMSP3 are induced to several B cell epitopes. The presence of PvMSP3 cytophilic antibodies (IgG1 and IgG3), suggests that this mechanism could also occur in P. vivax.

Download full-text


Available from: Josué da Costa Lima-Junior,
1 Follower
50 Reads
    • "Even if these repeats have a role in host cell specificity, other sheep infecting Babesia parasites of the B. motasi-like group have established other interactions to specifically infect sheep erythrocytes, since the sequences, composition and organisation of their rap-1 genes is radically different (Niu et al., 2013, 2014). Tandem repeat proteins have been shown to be immunodominant in Trypanosoma cruzi, as well as in Leishmania infantum and Plasmodium (Goto et al., 2006, 2008; Lima-Junior et al., 2011), and the number of repeats in T. cruzi FRA protein has been found to increase antibodies affinity but not antigenicity (Valiente-Gabioud et al., 2011). The role of repetitive regions of tandem repeat proteins as a decoy to divert the immune response from functional regions has long been suggested, but the precise role of these regions in the invasion process of parasite often remains to be proved. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Sheep babesiosis occurs mainly in tropical and subtropical areas. The sheep parasite Babesia sp. Xinjiang is widespread in China, and our goal is to characterize rap-1 (rhoptry-associated protein 1) gene diversity and expression as a first step of a long term goal aiming at developing a recombinant subunit vaccine. Seven different rap-1a genes were amplified in Babesia sp. Xinjiang, using degenerate primers designed from conserved motifs. Rap-1b and rap-1c gene types could not be identified. In all seven rap-1a genes, the 5' regions exhibited identical sequences over 936nt, and the 3' regions differed at 28 positions over 147nt, defining two types of genes designated α and β. The remaining 3' part varied from 72 to 360nt in length, depending on the gene. This region consists of a succession of two to ten 36nt repeats, which explains the size differences. Even if the nucleotide sequences varied, 6 repeats encoded the same stretch of amino acids. Transcription of at least four α and two β genes was demonstrated by standard RT-PCR. Copyright © 2015 Elsevier B.V. All rights reserved.
    Veterinary Parasitology 05/2015; 211(3-4). DOI:10.1016/j.vetpar.2015.04.030 · 2.46 Impact Factor
  • Source
    • "The function of each protein is unknown, and naturally acquired immune responses have so far only been studied against PvMSP3.10 (PvMSP3-α) [26]–[28], leaving much to be understood about the biological and immunogenic role this family of proteins has in terms of immunomodulation and protection. Finally, just as pvmsp3-α and pvmsp3-β have become genetic markers of diversity and tools for studying population genetics of P. vivax [213–23,53–60], other members of the family may be similarly suited. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Three members of the Plasmodium vivax merozoite surface protein-3 (PvMSP3) family (PvMSP3-α, PvMSP3-β and PvMSP3-γ) were initially characterized and later shown to be part of a larger highly diverse family, encoded by a cluster of genes arranged head-to-tail in chromosome 10. PvMSP3-α and PvMSP3-β have become genetic markers in epidemiological studies, and are being evaluated as vaccine candidates. This research investigates the gene and protein expression of the entire family and pertinent implications. A 60 kb multigene locus from chromosome 10 in P. vivax (Salvador 1 strain) was studied to classify the number of pvmsp3 genes present, and compare their transcription, translation and protein localization patterns during blood-stage development. Eleven pvmsp3 paralogs encode an N-terminal NLRNG signature motif, a central domain containing repeated variable heptad sequences, and conserved hydrophilic C-terminal features. One additional ORF in the locus lacks these features and was excluded as a member of the family. Transcripts representing all eleven pvmsp3 genes were detected in trophozoite- and schizont-stage RNA. Quantitative immunoblots using schizont-stage extracts and antibodies specific for each PvMSP3 protein demonstrated that all but PvMSP3.11 could be detected. Homologs were also detected by immunoblot in the closely related simian species, P. cynomolgi and P. knowlesi. Immunofluorescence assays confirmed that eight of the PvMSP3s are present in mature schizonts. Uniquely, PvMSP3.7 was expressed exclusively at the apical end of merozoites. Specific proteins were detected representing the expression of 10 out of 11 genes confirmed as members of the pvmsp3 family. Eight PvMSP3s were visualized surrounding merozoites. In contrast, PvMSP3.7 was detected at the apical end of the merozoites. Pvmsp3.11 transcripts were present, though no corresponding protein was detected. PvMSP3 functions remain unknown. The ten expressed PvMSP3s are predicted to have unique and complementary functions in merozoite biology.
    PLoS ONE 05/2013; 8(5):e63888. DOI:10.1371/journal.pone.0063888 · 3.23 Impact Factor
  • Source
    • "We demonstrated that the frequencies of individuals with IgG antibodies to PvMSP-3α and at least one of the three recombinant proteins representing PvMSP-3β were relatively high (68.2% and 79.1%, respectively). For PvMSP-3α, these findings confirm two recent studies performed in distinct endemic areas of the Brazilian Amazon, where 78% [19] and 58.4% [20] of individuals presented IgG antibodies to this protein. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A recent clinical trial in African children demonstrated the potential utility of merozoite surface protein (MSP)-3 as a vaccine against malaria. The present study evaluated the use of MSP-3 (PvMSP-3) as a target antigen in vaccine formulations against malaria caused by . Recombinant proteins representing MSP-3α and MSP-3β of were expressed as soluble histidine-tagged bacterial fusions. Antigenicity during natural infection was evaluated by detecting specific antibodies using sera from individuals living in endemic areas of Brazil. A large proportion of infected individuals presented IgG antibodies to PvMSP-3α (68.2%) and at least 1 recombinant protein representing PvMSP-3β (79.1%). In spite of the large responder frequency, reactivity to both antigens was significantly lower than was observed for the immunodominant epitope present on the 19-kDa C-terminal region of PvMSP-1. Immunogenicity of the recombinant proteins was studied in mice in the absence or presence of different adjuvant formulations. PvMSP-3β, but not PvMSP-3α, induced a TLR4-independent humoral immune response in the absence of any adjuvant formulation. The immunogenicity of the recombinant antigens were also tested in formulations containing different adjuvants (Alum, flagellin, CpG, Quil A,TiterMax® and incomplete Freunds adjuvant) and combinations of two adjuvants (Alum plus flagellin, and CpG plus flagellin). Recombinant PvMSP-3α and PvMSP-3β elicited higher antibody titers capable of recognizing infected erythrocytes harvested from malaria patients. Our results confirm that MSP-3 antigens are immunogenic during natural infection, and the corresponding recombinant proteins may be useful in elucidating their vaccine potential.
    PLoS ONE 02/2013; 8(2):e56061. DOI:10.1371/journal.pone.0056061 · 3.23 Impact Factor
Show more